Sorafenib is a kinase inhibitor drug approved for the treatment of primary kidney
cancer (advanced renal cell carcinoma), advanced primary liver cancer ...
Sorafenib (Nexavar) side effects, what it's used for, how it's given, how it works,
drug type, precautions and self care tips.
Hypersensitivity to sorafenib or to any of the excipients. ... Use sorafenib with
caution in patients who may have, or may develop prolongation of QTc, and ...
Sorafenib is a synthetic compound targeting growth signaling and angiogenesis.
Sorafenib blocks the enzyme RAF kinase, a critical component of the ...
sorafenib tosylate: Patient Information: The tosylate salt of sorafenib, a synthetic
compound targeting growth signaling and angiogenesis. Sorafenib blocks the ...
Nov 26, 2013 ... On November 22, 2013, the Food and Drug Administration (FDA) approved
sorafenib tosylate (Nexavar<sup>®</sup> tablets, made by Bayer Healthcare ...
Jun 13, 2005 ... Sorafenib (rINN), marketed as Nexavar by Bayer, is a drug approved for the
treatment of advanced renal cell carcinoma (primary kidney cancer) ...
Find patient medical information for sorafenib oral on WebMD including its uses,
side effects and safety, interactions, pictures, warnings and user ratings.
Oct 14, 2015 ... On November 22, 2013, the U. S. Food and Drug Administration approved
sorafenib (NEXAVAR tablets, Bayer Healthcare Pharmaceuticals ...
Easy to read patient leaflet for sorafenib. Includes indications, proper use, special
instructions, precautions, and possible side effects.